Follow
M Le Naour
M Le Naour
Unknown affiliation
Verified email at umn.edu
Title
Cited by
Cited by
Year
Bivalent Ligands That Target μ Opioid (MOP) and Cannabinoid1 (CB1) Receptors Are Potent Analgesics Devoid of Tolerance
M Le Naour, E Akgün, A Yekkirala, MM Lunzer, MD Powers, ...
Journal of medicinal chemistry 56 (13), 5505-5513, 2013
942013
An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia
M Pravetoni, M Le Naour, TM Harmon, AM Tucker, PS Portoghese, ...
Journal of Pharmacology and Experimental Therapeutics 341 (1), 225-232, 2012
932012
Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats
M Pravetoni, MD Raleigh, M Le Naour, AM Tucker, TM Harmon, JM Jones, ...
Vaccine 30 (31), 4617-4624, 2012
862012
A fentanyl vaccine alters fentanyl distribution and protects against fentanyl-induced effects in mice and rats
MD Raleigh, F Baruffaldi, SJ Peterson, M Le Naour, TM Harmon, ...
Journal of Pharmacology and Experimental Therapeutics 368 (2), 282-291, 2019
752019
Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens
M Pravetoni, M Le Naour, AM Tucker, TM Harmon, TM Hawley, ...
Journal of medicinal chemistry 56 (3), 915-923, 2013
662013
Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects
M Le Naour, MM Lunzer, MD Powers, AE Kalyuzhny, MA Benneyworth, ...
Journal of medicinal chemistry 57 (15), 6383-6392, 2014
422014
Effect of oxime ether incorporation in acyl indole derivatives on PPAR subtype selectivity
M Le Naour, V Leclerc, A Farce, DH Caignard, N Hennuyer, B Staels, ...
ChemMedChem 7 (12), 2179-2193, 2012
152012
Compositions and methods related to tauopathy
KH Ashe, X Zhao, MA Walters, DJ Hook, MCP Le Naour
US Patent 9,200,068, 2015
132015
Opioid Activity of Spinally Selective Analogues of N-Naphthoyl-β-naltrexamine in HEK-293 Cells and Mice
M Le Naour, MM Lunzer, MD Powers, PS Portoghese
Journal of medicinal chemistry 55 (2), 670-677, 2012
132012
Compositions and methods of treating opioid addiction
PR Pentel, PS Portoghese, M Pravetoni, MCP Le Naour
US Patent App. 14/029,568, 2014
82014
Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonists
A Hurtevent, M Le Naour, V Leclerc, P Carato, P Melnyk, N Hennuyer, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 35 (1), 524-538, 2020
32020
Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens
M Pravetoni, M Le Naour, AM Tucker, T Harmon, PS Portoghese, ...
Drug and Alcohol Dependence 140, e180, 2014
2014
JPET Fast Forward. Published on January 18, 2012 as DOI: 10.1124/jpet. 111.189506
M Pravetoni, M Le Naour, TM Harmon, AM Tucker, PS Portoghese, ...
2012
Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them
A Hurtevent, JM L'Helgoual'ch, P Carato, N Lebegue, V Leclerc, ...
US Patent App. 12/224,861, 2009
2009
New heterocyclic compounds are aldose reductase inhibitors useful to treat e.g. hyperglycemia, dyslipidemia, non-insulin-dependant type II diabetes, syndrome X, coronary artery …
LEN MORGAN, P CELINE, L NICOLAS, L VERONIQUE, B PASCAL, ...
FR Patent FR2921366 (A1), 2007
2007
NOUVEAUX DERIVES TETRACYCLIQUES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
LHCHJ MARTIAL, LEN MORGAN, B PASCAL, L NICOLAS, ...
FR Patent FR2903404 (A1), 2006
2006
The system can't perform the operation now. Try again later.
Articles 1–16